AI drug discovery startup Basecamp Research raises $140M
SiliconANGLEen
Basecamp Research Ltd. today announced that it has raised $140 million in funding from a group of prominent investors. S32, a fund affiliated with Google LLC co-founder Bill Maris, led the Series C round. It was joined by more than a dozen other investors. The group included NATO, Nvidia Corp. and the Anthology Fund, a […] The post AI drug discovery startup Basecamp Research raises $140M appeared first on SiliconANGLE .
This is a short summary published by AI Global Wire. The full article is owned and hosted by SiliconANGLE — open it there to read it in full.
Read the full story at SiliconANGLE- Verktyg
- Forskning
- Företag
Related AI news
- Oracle shifts agent controls toward data-layer securitySiliconANGLE · September 23, 2026
- Workforce economics emerges as AI reshapes the C-suiteSiliconANGLE · September 23, 2026
- Meta's standoff with Amazon over Muse could be a sign of things to comeCNBC Technology · September 23, 2026
- A US-China AI Hotline Won't Be Ready For a WhileWIRED AI · September 23, 2026
- "We have a choice": AI leaders sound alarm at UNAxios · September 23, 2026
- Microsoft’s new Surface Mouse has haptic feedback and a customizable action buttonThe Verge · September 23, 2026